Starting in 2026, NIBRT training will be piloted at Heartland BioWorks’ Indianapolis headquarters with hands-on training beginning in 2027.

Johnson & Johnson has agreed to acquire Halda Therapeutics for $3.05 billion cash, in a deal designed to expand the buyer’s cancer pipeline with Halda’s precision oncology candidates, led by a ...

Artificial intelligence (AI) can predict how well patients with rectal cancer will respond to treatment by analyzing standard ...

For the first time, thanks to CRISPR scissors, the genome of reptiles has been edited. American researchers have managed to ...

Rehabilitation helps restore some function, but in many cases stroke survivors live with permanent motor and cognitive impairments, as well as an increased risk of depression, dementia and other ...

The global animal biotechnology market size is calculated at USD 30.97 billion in 2025 and is expected to reach around USD 72.6 billion by 2034, growing at a CAGR of 9.93% for the forecasted ...

Zymo Research, a global leader in next-generation sequencing (NGS), has entered a strategic partnership with biomodal, an omics-based ...

For the first time, scientists have grown functional, brain-like tissue without using any animal-derived materials or added ...

The 2025 Salmon Summit: Reconnecting Habitat, Restoring Rivers and Recovering Salmon was an impressive, one-day demonstration ...

With fresh tax relief and accelerating AI breakthroughs, select U.S. biotechs are entering a rare period of asymmetric upside ...

Biomedical innovations can transform health care and greatly alleviate health disparities. Their ability to advance health equity, however, relies on access, affordability, and ethical deployment.

Avalo deploys interpretable machine learning (IML) to develop more climate resilient varieties of crops such as sugarcane and ...